Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Market outline PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by products • Market overview • Consumables • Instruments PART 07: Market segmentation by end-user • Market overview • Hospitals and clinics • Clinical diagnostic laboratories • Homecare settings PART 08: Geographical segmentation • Market overview • POC blood gas and electrolyte market in Americas • POC blood gas and electrolyte market in EMEA • POC blood gas and electrolyte market in APAC PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Market challenges PART 11: Market trends • Paradigm shift from benchtop to portable POC blood gas and electrolyte devices • Data management and connectivity through interoperability • Shift from traditional central laboratory blood gas analysis to near-patient site testing PART 12: Vendor landscape • Competitive landscape PART 13: Key vendor analysis • Alere • F. Hoffmann-La Roche • Instrumentation Laboratory • Radiometer • Other prominent vendors PART 14: Appendix • List of abbreviations   List of Exhibits Exhibit 01: Flow of the market for POC blood gas and electrolyte market 2016 Exhibit 02: Advantages of POC blood gas and electrolyte devices Exhibit 03: Global POC blood gas and electrolyte market 2016-2021 ($ millions) Exhibit 04: Five forces analysis Exhibit 05: Global POC blood gas and electrolyte market by product 2016 Exhibit 06: Global POC blood gas and electrolyte market by consumables: Overview Exhibit 07: Global POC blood gas and electrolyte market by consumables 2016-2021 ($ millions) Exhibit 08: Market representation of the consumables segment of POC blood gas and electrolyte 2016-2021 Exhibit 09: Market overview of POC blood gas and electrolyte by instruments 2016 Exhibit 10: Global POC blood gas and electrolyte market by instruments 2016-2021 ($ millions) Exhibit 11: Market representation of the instrument segment of POC blood gas and electrolyte (2016-2021) Exhibit 12: Segmentation of global POC blood gas and electrolyte market by end-user 2016 Exhibit 13: Global POC blood gas and electrolyte market by end-user (2016) Exhibit 14: Buying criteria analysis: Global POC blood gas and electrolyte market 2016 Exhibit 15: Global POC blood gas and electrolyte market by geography in 2016 and 2021 ($ millions) Exhibit 16: Market overview: POC blood gas and electrolyte market in Americas Exhibit 17: Global POC blood gas and electrolyte market in Americas 2016-2021 ($ millions) Exhibit 18: Average length of stay (ALOS) for disease of the respiratory systems in the in-patient department for EMEA 2014 Exhibit 19: Market overview: POC blood gas and electrolyte market in EMEA Exhibit 20: Global POC blood gas and electrolyte market in EMEA 2016-2021 ($ millions) Exhibit 21: Market overview: POC blood gas and electrolyte market in APAC Exhibit 22: Global POC blood gas and electrolyte market in APAC 2016-2021($ millions) Exhibit 23: Global increase in older population from 2015 and 2030 (%) Exhibit 24: Advantage of POC testing Exhibit 25: Competitive structure analysis of global POC blood gas and electrolyte market 2016 Exhibit 26: Market penetration of key vendors in global POC blood gas and electrolyte market 2016 Exhibit 27: Strategic success factors for companies in global POC blood gas and electrolyte market 2016 Exhibit 28: Alere: Key highlights Exhibit 29: Alere: Strength assessment Exhibit 30: Alere: Strategy assessment Exhibit 31: Alere: Opportunity assessment Exhibit 32: F. Hoffmann-La Roche: Key highlights Exhibit 33: F. Hoffmann-La Roche: Strength assessment Exhibit 34: F. Hoffmann-La Roche: Strategy assessment Exhibit 35: F. Hoffmann-La Roche: Opportunity assessment Exhibit 36: Instrumentation Laboratory: Key highlights Exhibit 37: Instrumentation Laboratory: Strength assessment Exhibit 38: Instrumentation Laboratory: Strategy assessment Exhibit 39: Instrumentation Laboratory: Opportunity assessment Exhibit 40: Radiometer: Key highlights Exhibit 41: Radiometer: Strength assessment Exhibit 42: Radiometer: Strategy assessment Exhibit 43: Radiometer: Opportunity assessment

Alere, F. Hoffmann-La Roche, Instrumentation Laboratory, Radiometer, Abbott, Bayer, Cornley, Convergent Technologies, Edan Instruments, Erba Diagnostics, Fortress Diagnostics, i.SENS, JOKOH, LifeHealth, Medica, Nova Biomedical, OPTI Medical (Idexx), Perlong Medical, SENSACORE, Siemens Healthineers, Sphere Medical, and ZOLL Medical.